Desmoplastic Small Round Cell Tumor of the Pleura Successfully Treated with a Lower Dose of Pazopanib

Intern Med. 2016;55(17):2463-7. doi: 10.2169/internalmedicine.55.6395. Epub 2016 Sep 1.

Abstract

Desmoplastic small round cell tumor (DSRCT) is an aggressive mesenchymal tumor which primarily affects the abdomen. Even a multimodal approach rarely achieves durable remission and the optimal therapy for extended disease is unknown. We herein describe a rare case of DSRCT arising from the pleura in a 32-year-old man. Initial therapy, which included chemotherapy, surgery and radiotherapy, achieved a partial response for only two months. Although salvage chemotherapies had no effect, pazopanib treatment shrank the tumors and was well-tolerated on an outpatient basis. From the viewpoint of quality of life, pazopanib may therefore be a good therapeutic option for this aggressive disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use*
  • Combined Modality Therapy
  • Desmoplastic Small Round Cell Tumor / drug therapy*
  • Humans
  • Indazoles
  • Male
  • Pleural Neoplasms / drug therapy*
  • Pyrimidines / therapeutic use*
  • Quality of Life
  • Sulfonamides / therapeutic use*

Substances

  • Angiogenesis Inhibitors
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib